These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20035208)

  • 1. Carbapenemases: a brief review for pediatric infectious disease specialists.
    Overturf GD
    Pediatr Infect Dis J; 2010 Jan; 29(1):68-70. PubMed ID: 20035208
    [No Abstract]   [Full Text] [Related]  

  • 2. The emerging threat of acquired carbapenemases in Gram-negative bacteria.
    Cornaglia G; Rossolini GM
    Clin Microbiol Infect; 2010 Feb; 16(2):99-101. PubMed ID: 20085603
    [No Abstract]   [Full Text] [Related]  

  • 3. Emerging carbapenemases: a global perspective.
    Walsh TR
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S8-14. PubMed ID: 21129630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired metallo-beta-lactamases: an increasing clinical threat.
    Rossolini GM
    Clin Infect Dis; 2005 Dec; 41(11):1557-8. PubMed ID: 16267726
    [No Abstract]   [Full Text] [Related]  

  • 6. High prevalence of co-expression of newer beta-lactamases (ESBLs, Amp-C-beta-lactamases, and metallo-beta-lactamases) in gram-negative bacilli.
    Chatterjee SS; Karmacharya R; Madhup SK; Gautam V; Das A; Ray P
    Indian J Med Microbiol; 2010; 28(3):267-8. PubMed ID: 20644325
    [No Abstract]   [Full Text] [Related]  

  • 7. Parenteral carbapenems.
    Shah PM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():175-80. PubMed ID: 18154543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-spectrum beta-lactamases: a brief clinical update.
    Malloy AM; Campos JM
    Pediatr Infect Dis J; 2011 Dec; 30(12):1092-3. PubMed ID: 22105419
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.
    Carmeli Y; Akova M; Cornaglia G; Daikos GL; Garau J; Harbarth S; Rossolini GM; Souli M; Giamarellou H
    Clin Microbiol Infect; 2010 Feb; 16(2):102-11. PubMed ID: 20085604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond.
    Boyle DP; Zembower TR
    Urol Clin North Am; 2015 Nov; 42(4):493-505. PubMed ID: 26475946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of MRSA and Gram-negative bacteria with ESBLs and carbapenemases in patients from Northern Africa at a German hospital.
    Leistner R; Denkel LA; Gastmeier P; Werner G; Layer F; Pfeifer Y
    J Antimicrob Chemother; 2015 Nov; 70(11):3161-4. PubMed ID: 26216582
    [No Abstract]   [Full Text] [Related]  

  • 12. The current state of multidrug-resistant gram-negative bacilli in North America.
    Nicasio AM; Kuti JL; Nicolau DP
    Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial resistance, beta-lactam antibiotics and gramnegative bacteria at ICUs.
    Reisinger EC; Allerberger F
    Wien Klin Wochenschr; 1999 Jul; 111(14):537-8. PubMed ID: 10467639
    [No Abstract]   [Full Text] [Related]  

  • 14. [Beta-lactamase production and the patterns of bacterial resistance, 1988-1991].
    Rodríguez Noriega E; Morfín Otero R; Esparza Ahumada S
    Gac Med Mex; 1994; 130(5):355-60. PubMed ID: 7607365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs).
    Giamarellou H
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():1-16. PubMed ID: 15953019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of extended-spectrum beta-lactamases in South America.
    Villegas MV; Kattan JN; Quinteros MG; Casellas JM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():154-8. PubMed ID: 18154539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli.
    Lee K; Kim CK; Yong D; Jeong SH; Yum JH; Seo YH; Docquier JD; Chong Y
    J Microbiol Methods; 2010 Nov; 83(2):149-52. PubMed ID: 20801167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of disk preparation on detection of metallo-beta-lactamase-producing isolates by the combined disk assay.
    Andrade SS; Picão RC; Campana EH; Nicoletti AG; Pignatari AC; Gales AC
    J Clin Microbiol; 2007 Jun; 45(6):2058-60. PubMed ID: 17409202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria.
    Akova M; Daikos GL; Tzouvelekis L; Carmeli Y
    Clin Microbiol Infect; 2012 May; 18(5):439-48. PubMed ID: 22507111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status report on carbapenemases: challenges and prospects.
    Patel G; Bonomo RA
    Expert Rev Anti Infect Ther; 2011 May; 9(5):555-70. PubMed ID: 21609267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.